Pharmacokinetic Optimisation of Angiotensin Converting Enzyme (ACE) Inhibitor Therapy

[1]  T. Unger,et al.  From tissue angiotensin converting enzyme inhibition to antihypertensive effect. , 1991, American journal of hypertension.

[2]  J. Kelly,et al.  Clinical Pharmacokinetics of the Newer ACE Inhibitors , 1990, Clinical pharmacokinetics.

[3]  P. Meredith,et al.  Concentration-effect analysis of antihypertensive drug responses. , 1990 .

[4]  P A Meredith,et al.  Kinetic-dynamic relations and individual responses to enalapril. , 1990, Hypertension.

[5]  V. Mooser,et al.  Reactive Hyperreninemia Is a Major Determinant of Plasma Angiotensin II During ACE Inhibition , 1990, Journal of cardiovascular pharmacology.

[6]  X. Chen,et al.  Captopril and ramiprilat protect against free radical injury in isolated working rat hearts. , 1989, Journal of molecular and cellular cardiology.

[7]  C. Johnston,et al.  Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors. , 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[8]  K. Lynn,et al.  The pharmacokinetics of angiotensin converting enzyme inhibitors in patients with renal impairment. , 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[9]  R. Vestal,et al.  Management of drug therapy in the elderly. , 1989, The New England journal of medicine.

[10]  P. Hayes,et al.  Pharmacokinetics of enalapril and lisinopril in subjects with normal and impaired hepatic function. , 1989, Journal of human hypertension.

[11]  J. Ménard,et al.  Need for plasma angiotensin measurements to investigate converting-enzyme inhibition in humans. , 1989, American heart journal.

[12]  J. McMurray,et al.  Captopril: a free radical scavenger. , 1989, British journal of clinical pharmacology.

[13]  W. Kirch,et al.  Angiotensin-Converting Enzyme Inhibitors , 1988 .

[14]  R. Schrier.  Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1) , 1988, The New England journal of medicine.

[15]  B. Healy.  Innovators for the 21st century: will we face a crisis in biomedical-research brainpower? , 1988, The New England journal of medicine.

[16]  G. Kochak,et al.  Pentopril‐Cimetidine Interaction Caused by a Reduction in Hepatic Blood Flow , 1988, Journal of clinical pharmacology.

[17]  G. Schubiger,et al.  Enalapril for pregnancy-induced hypertension: acute renal failure in a neonate. , 1988, Annals of internal medicine.

[18]  B Waeber,et al.  Individual responses to converting enzyme inhibitors and calcium antagonists. , 1988, Hypertension.

[19]  G. Kochak,et al.  Inhibition of renal clearance of furosemide by pentopril, an angiotensin—converting enzyme inhibitor , 1987, Clinical pharmacology and therapeutics.

[20]  K. Dickstein,et al.  The pharmacokinetics of enalapril in hospitalized patients with congestive heart failure. , 1987, British journal of clinical pharmacology.

[21]  W. V. van Gilst,et al.  Potentiation of isosorbide dinitrate-induced coronary dilatation by captopril. , 1987, Journal of cardiovascular pharmacology.

[22]  M. Packer,et al.  Comparison of captopril and enalapril in patients with severe chronic heart failure. , 1986, The New England journal of medicine.

[23]  G. Nyberg,et al.  Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. , 1986, British medical journal.

[24]  Y. Taguma,et al.  Effect of captopril on heavy proteinuria in azotemic diabetics. , 1985, The New England journal of medicine.

[25]  M. Pfeffer,et al.  Influence of Chronic Captopril Therapy on the Infarcted Left Ventricle of the Rat , 1985, Circulation research.

[26]  B. Waeber,et al.  True Versus Immunoreactive Angiotensin II in Human Plasma , 1985, Hypertension.

[27]  C. Johnston,et al.  Enalapril (MK421) activation in man: importance of liver status. , 1985, British journal of clinical pharmacology.

[28]  P. Vert,et al.  CAPTOPRIL ADMINISTRATION IN PREGNANCY IMPAIRS FETAL ANGIOTENSIN CONVERTING ENZYME ACTIVITY AND NEONATAL ADAPTATION , 1984, The Lancet.

[29]  M. Packer,et al.  Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure. , 1984, Journal of the American College of Cardiology.

[30]  B. Waeber,et al.  Does pharmacological profiling of a new drug in normotensive volunteers provide a useful guideline to antihypertensive therapy? , 1983, Hypertension.

[31]  S. Singhvi,et al.  Renal handling of captopril: Effect of probenecid , 1982, Clinical pharmacology and therapeutics.

[32]  K. Silberbauer,et al.  Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide. , 1982, British journal of clinical pharmacology.

[33]  J. Laragh,et al.  Captopril Compared with Other Antirenin System Agents in Hypertensive Patients: Its Triphasic Effects on Blood Pressure and Its Use to Identify and Treat the Renin Factor , 1980, Hypertension.

[34]  H. Gavras,et al.  Discrepancy Between Antihypertensive Effect and Angiotensin Converting Enzyme Inhibition by Captopril , 1980, Hypertension.

[35]  B Rubin,et al.  Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. , 1977, Science.

[36]  Skidgel Ra,et al.  The angiotensin I-converting enzyme. , 1977 .

[37]  J. Ménard,et al.  Treating the individual hypertensive patient: considerations on dose, sequential monotherapy and drug combinations. , 1990, Journal of hypertension.

[38]  N. Sharpe.  Cardiac effects of angiotensin converting enzyme inhibitors , 1990, Cardiovascular drugs and therapy.

[39]  J. McNeil,et al.  Comparative pharmacokinetics of enalapril and lisinopril, alone and with hydralazine. , 1989, Journal of human hypertension.

[40]  M. Burnier,et al.  Pharmacokinetics of angiotensin converting enzyme inhibitors. , 1989, British journal of clinical pharmacology.

[41]  G. Garanin.  A comparison of once-daily antihypertensive therapy with captopril and enalapril , 1986 .